MED LIFE SA financials
MED LIFE SA
Country: RO Reporting currency: RON Latest annual report: 2022-12-31
LEI:
254900RJWPQ4SLGCPI85 Financial statements
(RON, as reported — unscaled; 102 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Operating expenses | RON 1.72B | RON 1.27B |
| Depreciation & amortisation | RON 152.4M | RON 113.8M |
| Operating profit (EBIT) | RON 94.2M | RON 171.9M |
| Finance costs | RON 42.5M | RON 27.5M |
| Profit before tax | RON 49.6M | RON 135.4M |
| Income tax expense | RON 12.1M | RON 22.5M |
| Profit for the year | RON 37.4M | RON 112.9M |
| — attributable to owners | RON 32.2M | RON 102.6M |
| — attributable to NCI | RON 5.3M | RON 10.3M |
| Total comprehensive income | RON 93.1M | RON 112.9M |
| Per share | ||
| Basic EPS | RON 0.24 | RON 0.77 |
| Diluted EPS | RON 0.24 | RON 0.77 |
| Free cash flow / share | RON 0.23 | RON 0.93 |
| Cash flow statement | ||
| Cash generated from operations | RON 228.6M | RON 282.6M |
| Net cash from operating activities | RON 184.6M | RON 227.4M |
| Net cash from investing activities | -RON 485.9M | -RON 149.4M |
| Purchase of PP&E (capex) | RON 149.1M | RON 91.5M |
| Purchase of intangibles | RON 20.2M | RON 5.4M |
| Net cash from financing activities | RON 254.5M | -RON 24.1M |
| Dividends paid | RON 136.9K | RON 70.0K |
| Proceeds from borrowings | RON 411.8M | RON 84.2M |
| Repayments of borrowings | RON 73.4M | RON 56.2M |
| Lease liability payments | RON 69.4M | RON 46.7M |
| Balance sheet | ||
| Total assets | RON 2.15B | RON 1.42B |
| Non-current assets | RON 1.69B | RON 1.03B |
| Property, plant & equipment | RON 828.5M | RON 552.2M |
| Right-of-use assets | RON 306.4M | RON 190.7M |
| Intangible assets & goodwill | RON 368.7M | RON 199.7M |
| Current assets | RON 465.4M | RON 382.8M |
| Inventories | RON 98.8M | RON 74.2M |
| Cash & equivalents | RON 89.1M | RON 135.9M |
| Total equity | RON 482.0M | RON 381.4M |
| — attributable to owners | RON 416.8M | RON 338.1M |
| Non-controlling interests | RON 65.3M | RON 43.3M |
| Non-current liabilities | RON 1.09B | RON 621.6M |
| Long-term borrowings | RON 803.3M | RON 440.8M |
| Lease liabilities (non-current) | RON 225.2M | RON 149.7M |
| Current liabilities | RON 575.6M | RON 414.6M |
| Current portion of long-term borrowings | RON 55.7M | RON 58.5M |
| Lease liabilities (current) | RON 77.1M | RON 52.6M |
| Trade & other payables | RON 335.4M | RON 224.2M |
| Deferred tax liabilities | RON 44.3M | RON 23.6M |
| Derived metrics | ||
| Free cash flow | RON 35.5M | RON 135.9M |
| Operating margin | 5.2% | 12.0% |
| Net margin | 2.1% | 7.9% |
| Return on equity | 7.8% | 29.6% |
| Cash conversion ratio | 4.93× | 2.01× |
| Capex coverage | 1.24× | 2.48× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -RON 12.2M | -RON 5.9M |
| Adjustments For Decrease Increase In Trade Account Receivable | -RON 36.1M | -RON 6.5M |
| Adjustments For Depreciation and Amortisation Expense | RON 152.4M | RON 113.8M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | RON 4.9M | RON 5.3M |
| Adjustments For Increase Decrease In Trade Account Payable | RON 31.2M | RON 8.8M |
| Adjustments For Interest Expense | RON 42.5M | RON 27.5M |
| Adjustments For Interest Income | RON 1.3M | RON 149.9K |
| Adjustments For Provisions | RON 625.5K | RON 782.8K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | RON 3.5M | RON 9.1M |
| Bank Overdrafts Classified As Cash Equivalents | RON 27.8M | RON 25.5M |
| Cash Flows From Used In Operations Before Changes In Working Capital | RON 245.5M | RON 287.1M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | RON 316.6M | RON 52.5M |
| Comprehensive Income Attributable To Noncontrolling Interests | RON 6.9M | RON 10.3M |
| Comprehensive Income Attributable To Owners of Parent | RON 86.2M | RON 102.6M |
| Cost of Merchandise Sold | RON 210.0M | RON 106.2M |
| Current Provisions | RON 9.8M | RON 8.0M |
| Current Tax Liabilities Current | RON 814.5K | RON 1.5M |
| Dividends Recognised As Distributions To Noncontrolling Interests | — | RON 217.7K |
| Equity and Liabilities | RON 2.15B | RON 1.42B |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade Receivables | RON 4.9M | RON 5.3M |
| Income Tax Relating To Changes In Revaluation Surplus of Other Comprehensive Income | RON 10.6M | RON 0 |
| Income Taxes Paid Refund Classified As Operating Activities | RON 12.8M | RON 26.6M |
| Increase Decrease In Cash and Cash Equivalents | -RON 46.8M | RON 53.9M |
| Increase Decrease Through Acquisition of Subsidiary | RON 21.9M | RON 7.4M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -RON 16.6M | -RON 4.7M |
| Increase Decrease Through Transfer To Statutory Reserve | RON 0 | RON 0 |
| Increase Decrease Through Transfers and Other Changes Equity | RON 0 | RON 0 |
| Increase Decrease Through Treasury Share Transactions | RON 8.6M | RON 320.2K |
| Intangible Assets Other Than Goodwill | RON 100.2M | RON 60.6M |
| Interest Paid Classified As Operating Activities | RON 32.4M | RON 28.8M |
| Interest Received Classified As Operating Activities | RON 1.3M | RON 149.9K |
| Liabilities | RON 1.67B | RON 1.04B |
| Other Assets | RON 44.4M | RON 24.4M |
| Other Comprehensive Income | RON 55.7M | RON 0 |
| Other Comprehensive Income Attributable To Noncontrolling Interests | RON 1.7M | RON 0 |
| Other Comprehensive Income Attributable To Owners of Parent | RON 54.0M | RON 0 |
| Other Comprehensive Income Before Tax Gains Losses On Revaluation | RON 66.3M | RON 0 |
| Other Finance Cost | RON 2.2M | RON 9.0M |
| Other Noncurrent Financial Assets | RON 82.8M | RON 31.6M |
| Other Nonfinancial Liabilities | RON 69.0M | RON 44.3M |
| Other Operating Income Expense | -RON 109.9M | -RON 79.6M |
| Other Reserves | RON 204.6M | RON 137.3M |
| Other Revenue | RON 14.1M | RON 10.4M |
| Payments From Changes In Ownership Interests In Subsidiaries | RON 6.5M | RON 1.7M |
| Payments To Acquire Or Redeem Entitys Shares | RON 7.9M | RON 3.7M |
| Prepayments | RON 11.8M | RON 8.0M |
| Purchase of Treasury Shares | RON 7.9M | RON 3.7M |
| Retained Earnings | RON 131.6M | RON 122.4M |
| Revenue and Operating Income | RON 1.81B | RON 1.44B |
| Revenue From Contracts With Customers | RON 1.80B | RON 1.43B |
| Social Security Contributions | RON 15.9M | RON 12.2M |
| Trade Receivables | RON 221.4M | RON 140.4M |
| Treasury Shares | RON 3.2M | RON 4.0M |
| Wages and Salaries | RON 442.9M | RON 333.8M |
Methodology
Every line item above is a fact tagged in MED LIFE SA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (RON), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.